Administration for Developmental Disabilities, 38650 [E6-10578]
Download as PDF
<![CDATA[
38650
Federal Register / Vol. 71, No. 130 / Friday, July 7, 2006 / Notices
Dated: June 28, 2006.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E6–10587 Filed 7–6–06; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
cprice-sewell on PROD1PC66 with NOTICES
Administration for Developmental
Disabilities
Award To: Oregon Health & Science
University, Child Development &
Rehabilitation Center.
Purpose: To supplement a grant
award for support of ‘‘Making It Real:
Participatory Action Research (PAR) for
University Centers for Excellence in
Developmental Disabilities (UCEDDs)’’.
Amount of Award: $65,000 for one
year.
Project Period: 7/1/2006—6/30/2007.
Justification for Exception to
Competition: After consulting with
relevant, informed sources, including
individuals with developmental
disabilities and their families, the
Administration for Developmental
Disabilities (ADD) determined that it
was beneficial to continue funding the
Oregon Health & Science University,
Child Development & Rehabilitation
Center project to strengthen and expand
the inclusion of people with
developmental disabilities and their
family members in participatory action
research projects at University Centers
for Excellence in Developmental
Disabilities (UCEDDs).
The Oregon Institute on Disability &
Development, the Oregon Health and
Science University, Child Development
and Rehabilitation Center will receive a
sole source program expansion
supplemental grant for ‘‘Making It Real:
Participatory Action Research (PAR) for
UCEDDs,’’ a training initiative on the
critical and emerging needs of
individuals with developmental
disabilities and their families. Through
the project, a tool kit is being created
that will include tested educational
modules on participatory action
research. Through the creation of the
toolkit, every UCEDD will be able to
access resources that will enhance and
increase PAR and support initiatives
that are most meaningful to people with
developmental disabilities and their
families. It will also be available to
individuals with developmental
disabilities, family members, advocacy
groups, and other interested
VerDate Aug<31>2005
15:46 Jul 06, 2006
Jkt 208001
organizations. By continuing funding of
this project, additional resources will be
developed, including materials in
Spanish. In addition, the expansion
supplement will allow for more time
and resources to enhance training and
dissemination efforts.
The Administration for Children and
Families intends to supplement the
current grant by $65,000. The grantee
will continue to provide a 25 percent
match.
FOR FURTHER INFORMATION CONTACT:
Jennifer G. Johnson, Ed.D., Program
Specialist, Administration on
Developmental Disabilities, 200
Independence Avenue, SW., Room 405–
D, Washington, DC 20201. Telephone:
202/690–5982 (v); 202/205–8037 (f). Email: jennifer.johnson@acf.hhs.gov.
Dated: June 21, 2006.
Patricia A. Morrissey,
Commissioner, Administration for
Developmental Disabilities.
[FR Doc. E6–10578 Filed 7–6–06; 8:45 am]
BILLING CODE 4184–01–P
was signed into law on October 22,
1994. AMDUCA allows veterinarians to
prescribe extralabel uses of approved
animal drugs and approved human
drugs for animals under certain
conditions. An extralabel use must be
by or on the order of a licensed
veterinarian within the context of a
veterinarian-client-patient relationship
and must be in conformance with the
implementing regulations published in
part 530 (21 CFR part 530). A list of
drugs specifically prohibited from
extralabel use in animals is in § 530.41.
With the enactment of AMDUCA and
the issuance of implementing
regulations, FDA is withdrawing CPG
7125.35 because it is obsolete. On
September 24, 1998, a CPG section
615.100 entitled ‘‘Extralabel Use of New
Animal Drugs in Food-Producing
Animals (CPG 7125.06)’’ was withdrawn
for the same reason (63 FR 51074).
Dated: June 20, 2006.
Margaret O’K. Glavin,
Associate Commissioner for Regulatory
Affairs.
[FR Doc. E6–10672 Filed 7–6–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4160–01–S
Food and Drug Administration
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[Docket No. 1990D–0428]
Human-Labeled Drugs Distributed and
Used in Animal Medicine; Withdrawal
of Compliance Policy Guide
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; withdrawal.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
[Docket No. 2006D–0214]
Streptomycin Residues in Cattle
Tissues; Withdrawal of Compliance
Policy Guide
AGENCY:
The Food and Drug
Administration (FDA) is announcing the
withdrawal of a compliance policy
guide (CPG) that was issued on March
19, 1991.
DATES: July 7, 2006.
FOR FURTHER INFORMATION CONTACT:
Diane D. Jeang, Division of Compliance
Policy (HFC–230), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 240–632–6833.
SUPPLEMENTARY INFORMATION: In a notice
published in the Federal Register of
July 30, 1992 (57 FR 33729), FDA
announced the availability of a revised
CPG 7125.35 entitled ‘‘Human-Labeled
Drugs Distributed and Used in Animal
Medicine.’’ The CPG is being withdrawn
because it is obsolete. This CPG
explained how FDA would exercise its
enforcement discretion with respect to
the distribution and use of humanlabeled drug products for use in
animals.
The Animal Medicinal Drug Use
Clarification Act of 1994 (AMDUCA)
SUMMARY:
Food and Drug Administration
Food and Drug Administration,
HHS.
ACTION:
Notice; withdrawal.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
withdrawal of the compliance policy
guide (CPG) entitled ‘‘Sec. 616.100
Streptomycin Residues in Cattle Tissues
(CPG 7125.22).’’ This CPG is obsolete.
DATES: The withdrawal is effective July
7, 2006.
FOR FURTHER INFORMATION CONTACT:
Diane D. Jeang, Division ofCompliance
Policy (HFC–230), Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857, 240–632–6833.
SUPPLEMENTARY INFORMATION: FDA
issued the CGP entitled ‘‘Sec. 616.100
Streptomycin Residues in Cattle Tissues
(CPG 7125.22)’’ on October 1, 1980. The
CPG was issued because there were no
published tolerances for residues of
streptomycin in cattle tissue and the
available data supported an action level
of 2 part per million (ppm)
streptomycin/dihydrostreptomycin
E:\FR\FM\07JYN1.SGM
07JYN1
]]>Agencies
[Federal Register Volume 71, Number 130 (Friday, July 7, 2006)]
[Notices]
[Page 38650]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-10578]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Administration for Developmental Disabilities
Award To: Oregon Health & Science University, Child Development &
Rehabilitation Center.
Purpose: To supplement a grant award for support of ``Making It
Real: Participatory Action Research (PAR) for University Centers for
Excellence in Developmental Disabilities (UCEDDs)''.
Amount of Award: $65,000 for one year.
Project Period: 7/1/2006--6/30/2007.
Justification for Exception to Competition: After consulting with
relevant, informed sources, including individuals with developmental
disabilities and their families, the Administration for Developmental
Disabilities (ADD) determined that it was beneficial to continue
funding the Oregon Health & Science University, Child Development &
Rehabilitation Center project to strengthen and expand the inclusion of
people with developmental disabilities and their family members in
participatory action research projects at University Centers for
Excellence in Developmental Disabilities (UCEDDs).
The Oregon Institute on Disability & Development, the Oregon Health
and Science University, Child Development and Rehabilitation Center
will receive a sole source program expansion supplemental grant for
``Making It Real: Participatory Action Research (PAR) for UCEDDs,'' a
training initiative on the critical and emerging needs of individuals
with developmental disabilities and their families. Through the
project, a tool kit is being created that will include tested
educational modules on participatory action research. Through the
creation of the toolkit, every UCEDD will be able to access resources
that will enhance and increase PAR and support initiatives that are
most meaningful to people with developmental disabilities and their
families. It will also be available to individuals with developmental
disabilities, family members, advocacy groups, and other interested
organizations. By continuing funding of this project, additional
resources will be developed, including materials in Spanish. In
addition, the expansion supplement will allow for more time and
resources to enhance training and dissemination efforts.
The Administration for Children and Families intends to supplement
the current grant by $65,000. The grantee will continue to provide a 25
percent match.
FOR FURTHER INFORMATION CONTACT: Jennifer G. Johnson, Ed.D., Program
Specialist, Administration on Developmental Disabilities, 200
Independence Avenue, SW., Room 405-D, Washington, DC 20201. Telephone:
202/690-5982 (v); 202/205-8037 (f). E-mail:
jennifer.johnson@acf.hhs.gov.
Dated: June 21, 2006.
Patricia A. Morrissey,
Commissioner, Administration for Developmental Disabilities.
[FR Doc. E6-10578 Filed 7-6-06; 8:45 am]
BILLING CODE 4184-01-P
